CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-30 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +1,736 | $3.60 | $6K | 2,443 |
| 2025-06-30 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +1,736 | $3.60 | $6K | 2,443 |
| 2025-06-30 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +1,736 | $3.60 | $6K | 3,394 |
| 2025-06-30 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +1,736 | $3.60 | $6K | 3,394 |
| 2025-03-31 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +18,939 | $0.33 | $6K | 21,211 |
| 2025-03-31 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +18,939 | $0.33 | $6K | 21,211 |
| 2025-03-31 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +18,939 | $0.33 | $6K | 49,744 |
| 2025-03-31 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +18,939 | $0.33 | $6K | 49,744 |
| 2024-12-31 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +4,544 | $0.92 | $4K | 30,805 |
| 2024-12-31 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +4,544 | $0.92 | $4K | 30,805 |
| 2024-09-30 | Levy Oded Director | Grant or award · Stock Options (Right to Buy) | +18,686 | $0.22 | $4K | 26,261 |
| 2024-09-30 | Lau Stanley K. Director | Grant or award · Stock Options (Right to Buy) | +18,686 | $0.22 | $4K | 26,261 |
| 2024-09-30 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +18,686 | $0.22 | $4K | 26,261 |
| 2024-09-30 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +18,686 | $0.22 | $4K | 26,261 |
| 2024-09-06 | Dogan Timur Chief Technology Officer | Purchase | +68,965 | $0.29 | $20K | 197,310 |
| 2024-09-06 | Dogan Meeshanthini Chief Executive Officer | Purchase | +68,965 | $0.29 | $20K | 1,655,429 |
| 2024-09-06 | Dogan Meeshanthini Chief Executive Officer | Purchase | +68,965 | $0.29 | $20K | 1,655,429 |
| 2024-09-06 | Dogan Timur Chief Technology Officer | Purchase | +68,965 | $0.29 | $20K | 197,310 |
| 2024-09-06 | Philibert Robert Chief Medical Officer | Purchase | +26,615 | $0.29 | $8K | 1,676,407 |
| 2024-09-06 | Philibert Robert Chief Medical Officer | Purchase | +7,460 | $0.28 | $2K | 1,683,867 |
Page 2 of 7 · 137 trades